1

Brazil Infectious Diagnostics Market Outlook to 2021

Now Available at iData Insights

Brazil Infectious Diagnostics Market Outlook to 2021 Summary GlobalDatas new report, "Brazil

Infectious Diagnostics Market Outlook to 2021", provides key market data on the Brazil Infectious

Diagnostics market. The report provides value, in millions of US dollars within market segments -

Hepatitis Viruses, Retroviruses, Infectious Diagnostics Multiple Parameters Panels, Bacteriology, Nucleic

Acid Testing Instruments, Other Virology, Infectious Diagnostics Rapid Tests & POC and Parasitology &

Mycology. The report also provides company shares and distribution shares data for the market

category, and global corporate-level profiles of the key market participants. Based on the availability of

data for the particular category and country, information related to pipeline products, news and deals is

available in the report. Extensive interviews are conducted with industry experts to validate the market

size, company share and distribution share data and analysis. Scope - Infectious Diagnostics market

includes Hepatitis Viruses, Retroviruses, Infectious Diagnostics Multiple Parameters Panels, Bacteriology,

Nucleic Acid Testing Instruments, Other Virology, Infectious Diagnostics Rapid Tests & POC and

Parasitology & Mycology. - Annualized market revenues (USD million) data for each of the market

categories. Data is provided from 2007 to 2014 and forecast to 2021. - 2014 company shares and

distribution shares data for Infectious Diagnostics market. - Global corporate-level profiles of key

companies operating within the Brazil Infectious Diagnostics market. - Key players covered include

Siemens Healthcare, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Hologic, Inc., Qiagen N.V., Becton,

Dickinson and Company, Danaher Corporation and Alere Inc.. Reasons to buy - Develop business

strategies by identifying the key market segments poised for strong growth in the future. - Develop

market-entry and market expansion strategies. - Design competition strategies by identifying who-

stands-where in the market. - Develop investment strategies by identifying the key market segments

expected to register strong growth in the near future. - What are the key distribution channels and

whats the most preferred mode of product distribution - Identify, understand and capitalize.

Browse Complete Report with TOC @ http://www.idatainsights.com/reports-landing-

page.php?id=161227/brazil-infectious-diagnostics-market-outlook-to-2021

To Get Sample Copy of Report visit @ http://www.idatainsights.com/reports-landing-

page.php?id=161227/brazil-infectious-diagnostics-market-outlook-to-2021

Table of Contents

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 3

1.2 List of Figures 3

2 Introduction 4

2.1 What Is This Report About? 4

2

2.2 Infectious Diagnostics Market Segmentation 4

2.3 Definitions of Markets Covered in the Report 5

3 Infectious Diagnostics Market, Brazil 7

3.1 Infectious Diagnostics Market, Brazil, Revenue ($m), 2007-2014 7

3.2 Infectious Diagnostics Market, Brazil, Revenue ($m), 2014-2021 9

3.2.1 Infectious Diagnostics Rapid Tests & POC Market, Brazil, Revenue ($m), by Segment, 2007-2014 11

3.2.2 Infectious Diagnostics Rapid Tests & POC Market, Brazil, Revenue ($m), by Segment, 2014-2021 13

3.3 Infectious Diagnostics Market, Brazil, Distribution Share by Revenue ($m), 2013-2014 15

3.4 Infectious Diagnostics Market, Brazil, Company Share by Revenue ($m), 2014 16

4 Overview of Key Companies in Brazil, Infectious Diagnostics Market 18

4.1 Abbott Laboratories 18

4.1.1 Company Overview 18

4.2 Siemens Healthcare 18

4.2.1 Company Overview 18

4.3 F. Hoffmann-La Roche Ltd. 18

4.3.1 Company Overview 18

4.4 Qiagen N.V. 19

4.4.1 Company Overview 19

4.5 bioMerieux S.A. 19

4.5.1 Company Overview 19

4.6 DiaSorin S.p.A 19

4.6.1 Company Overview 19

4.7 Alere Inc. 20

4.7.1 Company Overview 20

5 Infectious Diagnostics Market Pipeline Products 21

6 Financial Deals Landscape 33

6.1 Partnerships 33

6.1.1 Biocartis Enters into Licensing and Development Agreement with Microbiome 33

3

6.1.2 Globavir Enters into Co-Development Agreement with Biomanguinhos 34

7 Recent Developments 35

7.1 Strategy And Business Planning 35

7.1.1 Oct 22, 2014: ERBA Diagnostics Enters Brazilian Market; Offers In Vitro Diagnostics to Hospitals,

Testing Labs and Physicians Clinics 35

8 Appendix 36

8.1 Research Methodology 37

8.1.1 Coverage 37

8.1.2 Secondary Research 37

8.1.3 Primary Research 37

8.1.4 Company Share Analysis 38

8.1.5 Distribution Share Analysis 38

8.2 GlobalData Consulting 38

8.3 Contact Us 38

8.4 Disclaimer 39

Read More http://www.idatainsights.com/reports-landing-page.php?id=161227/brazil-infectious-

diagnostics-market-outlook-to-2021

About Us:

iData Insights which operates under Precision Research and Consulting Private Limited is a leading

market research information aggregator and marketing research consulting firm. We conduct both

primary and secondary research. Our work does not end with research it is also involved in distributing

reports for different companies . We provide actionable recommendations and provide our expertise for

business success today and tomorrow. It is our goal to be a partner to our clients in the exploration and

discovery, and then be their guide in the implementation of changes that will make a difference to their

bottom line.

ContactUs: iData Insights Tel: 1-866-237-2965 Web: http://www.idatainsights.com Email: info@idatainsights.com About iData Insights

We work around the clock until our clients are completely satisfied with their promised results. It is our

mission to provide timely services coupled with acute client care to create a long-lasting relationship

with you. We deliver on our promise to provide results that are essential to the success of your

company. We believe that by doing so, we will earn the trust of our clients for future projects